1st Counsel – Lifestyle
Author:
Edgewise Therapeutics
Edgewise Announces Positive Long-Term Sevasemten Data Demonstrating Sustained Functional Stabilization in Becker Muscular Dystrophy Through 3.5 Years of Follow-Up
March 10, 2026